CRISPR Therapeutics AG (CRSP)
50.76
+4.37
(+9.42%)
USD |
NASDAQ |
Nov 01, 16:00
50.80
+0.04
(+0.08%)
After-Hours: 20:00
CRISPR Therapeutics Price to Book Value: 2.182 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.182 |
| October 31, 2024 | 1.994 |
| October 30, 2024 | 2.060 |
| October 29, 2024 | 2.104 |
| October 28, 2024 | 2.137 |
| October 25, 2024 | 2.036 |
| October 24, 2024 | 2.061 |
| October 23, 2024 | 1.977 |
| October 22, 2024 | 2.065 |
| October 21, 2024 | 2.085 |
| October 18, 2024 | 2.103 |
| October 17, 2024 | 2.076 |
| October 16, 2024 | 2.106 |
| October 15, 2024 | 2.066 |
| October 14, 2024 | 2.056 |
| October 11, 2024 | 2.014 |
| October 10, 2024 | 1.951 |
| October 09, 2024 | 1.952 |
| October 08, 2024 | 1.943 |
| October 07, 2024 | 1.955 |
| October 04, 2024 | 1.950 |
| October 03, 2024 | 1.930 |
| October 02, 2024 | 1.965 |
| October 01, 2024 | 1.959 |
| September 30, 2024 | 2.020 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.034 |
| September 26, 2024 | 1.998 |
| September 25, 2024 | 1.974 |
| September 24, 2024 | 2.011 |
| September 23, 2024 | 2.009 |
| September 20, 2024 | 2.071 |
| September 19, 2024 | 2.127 |
| September 18, 2024 | 2.132 |
| September 17, 2024 | 2.144 |
| September 16, 2024 | 2.052 |
| September 13, 2024 | 2.104 |
| September 12, 2024 | 1.973 |
| September 11, 2024 | 1.953 |
| September 10, 2024 | 1.960 |
| September 09, 2024 | 1.929 |
| September 06, 2024 | 1.918 |
| September 05, 2024 | 1.945 |
| September 04, 2024 | 1.936 |
| September 03, 2024 | 1.957 |
| August 30, 2024 | 2.051 |
| August 29, 2024 | 2.044 |
| August 28, 2024 | 2.041 |
| August 27, 2024 | 2.074 |
| August 26, 2024 | 2.114 |
| August 23, 2024 | 2.093 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.492
Minimum
May 09 2022
9.329
Maximum
Jan 14 2021
3.454
Average
2.693
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 8.230 |
| AC Immune SA | 2.162 |
| Addex Therapeutics Ltd | 0.8125 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.174 |
Price to Book Value Related Metrics
| Price | 50.76 |
| Earnings Yield | -6.30% |
| Market Cap | 4.323B |